VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 335 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2017. The put-call ratio across all filers is 1.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $6,000 | +50.0% | 300 | 0.0% | 0.00% | – |
| Q3 2017 | $4,000 | -20.0% | 300 | 0.0% | 0.00% | – |
| Q2 2017 | $5,000 | +66.7% | 300 | 0.0% | 0.00% | – |
| Q1 2017 | $3,000 | -25.0% | 300 | 0.0% | 0.00% | – |
| Q4 2016 | $4,000 | -42.9% | 300 | 0.0% | 0.00% | – |
| Q3 2016 | $7,000 | +16.7% | 300 | 0.0% | 0.00% | – |
| Q2 2016 | $6,000 | -83.8% | 300 | -78.8% | 0.00% | -100.0% |
| Q1 2016 | $37,000 | -74.3% | 1,415 | 0.0% | 0.00% | -71.4% |
| Q4 2015 | $144,000 | -72.0% | 1,415 | -50.8% | 0.01% | -72.0% |
| Q3 2015 | $514,000 | -19.7% | 2,875 | 0.0% | 0.02% | -13.8% |
| Q2 2015 | $640,000 | +28.8% | 2,875 | +15.5% | 0.03% | +26.1% |
| Q1 2015 | $497,000 | +99.6% | 2,490 | +43.0% | 0.02% | +91.7% |
| Q4 2014 | $249,000 | +29.7% | 1,741 | +18.4% | 0.01% | +20.0% |
| Q3 2014 | $192,000 | +3.8% | 1,470 | 0.0% | 0.01% | 0.0% |
| Q2 2014 | $185,000 | -4.6% | 1,470 | 0.0% | 0.01% | -9.1% |
| Q1 2014 | $194,000 | +288.0% | 1,470 | +241.9% | 0.01% | +266.7% |
| Q4 2013 | $50,000 | +900.0% | 430 | +795.8% | 0.00% | – |
| Q3 2013 | $5,000 | -99.5% | 48 | -99.6% | 0.00% | -100.0% |
| Q2 2013 | $1,022,000 | – | 11,867 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |